An injectable HIV treatment developed by British drugmaker GlaxoSmithKline is offering hope to patients in Uganda. Results of the WHO-approved trial are due in 2024 https://t.co/LyiRfSr7ng pic.twitter.com/CEGjXuO4im— Reuters (@Reuters) December 21, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


